CAMP

Camp4 Therapeutics Corp

Latest Form 4:Sale$1.6MbySchwab Andrew J. (Director) · filed Aug 31, 2026

Camp4 Therapeutics Corp (CAMP) has 16 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Aug 31, 2026.

The most active filer is Director Schwab Andrew J. with 5 filings. Insiders have net sold $2.4M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Joshua Mandel-Brehm
  • Employees:48
  • HQ:Cambridge, MA, US
  • IPO:2024-10-11

Insider Buying

$8.6M

reported purchases (SEC code P)

Insider Selling

$2.5M

reported sales (SEC code S)

Unique Insiders

9

in the rolling window

Market Cap

$205.6M

latest known value

Source
Sale$1.6MAug 31SEC ↗
Sale$45Aug 26SEC ↗
Sale$215KAug 21SEC ↗
Sale$521KAug 21SEC ↗
Sale$144KAug 21SEC ↗
Tardiff DanielFirst filing
Sale$8KAug 20SEC ↗
Gold KellyFirst in 11 months
Purchase$11KAug 5SEC ↗
Young Richard AFirst in 11 months
Purchase$27KAug 5SEC ↗
Maricich YuriFirst in 11 months
Purchase$11KAug 5SEC ↗
Mandel-Brehm JoshFirst in 11 months
Purchase$11KAug 5SEC ↗
Purchase$4.5MSep 15SEC ↗
Mandel-Brehm JoshFirst filing
Purchase$10KSep 11SEC ↗
Nashat AmirFirst filing
Purchase$2.0MSep 11SEC ↗
Maricich YuriFirst filing
Purchase$10KSep 11SEC ↗
Young Richard AFirst filing
Purchase$25KSep 11SEC ↗
Gold KellyFirst filing
Purchase$10KSep 11SEC ↗
Purchase$2.0MSep 11SEC ↗

Related companies

Camp4 Therapeutics Corp is in the Healthcare sector.